Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Galluzzi

Showing results (81-90 of 599) with videos related to

Pageof 60
Sort By:
Oncotarget|January 20, 2018
Lysosome-targeting agents in cancer therapyGuido Kroemer, Lorenzo Galluzzi
International Review of Cell and Molecular Biology|April 6, 2020
Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasisJohan Spetz, Lorenzo Galluzzi
Oncoimmunology|September 14, 2020
Mitochondrial control of innate immune signaling by irradiated cancer cellsTakahiro Yamazaki, Lorenzo Galluzzi
Oncoimmunology|March 4, 2021
Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agentsGiulia Petroni, Lorenzo Galluzzi
Cell Death & Disease|August 21, 2023
Cancer stem cell immunoediting by IFNγClaudia Galassi, Lorenzo Galluzzi
Cell Death and Differentiation|March 29, 2022
BAX and BAK dynamics control mitochondrial DNA release during apoptosisTakahiro Yamazaki, Lorenzo Galluzzi
Methods in Enzymology|June 14, 2014
Preface: oncometabolism: a new field of research with profound therapeutic implicationsLorenzo Galluzzi, Guido Kroemer
Nature Immunology|August 24, 2022
Immuno-epigenetic escape of cancer stem cellsLorenzo Galluzzi, Guido Kroemer
Cells|June 2, 2021
Immunology of Cell Death in Cancer ImmunotherapyLorenzo Galluzzi, Abhishek D Garg
Oncoimmunology|November 18, 2017
CD103<sup>+</sup> cells at the forefront of anticancer immunityClaire Vanpouille-Box, Lorenzo Galluzzi
Pageof 60

Showing results (81-90 of 599) with videos related to

Sort By:
Pageof 60
Oncotarget|January 20, 2018
Lysosome-targeting agents in cancer therapyGuido Kroemer, Lorenzo Galluzzi
International Review of Cell and Molecular Biology|April 6, 2020
Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasisJohan Spetz, Lorenzo Galluzzi
Oncoimmunology|September 14, 2020
Mitochondrial control of innate immune signaling by irradiated cancer cellsTakahiro Yamazaki, Lorenzo Galluzzi
Oncoimmunology|March 4, 2021
Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agentsGiulia Petroni, Lorenzo Galluzzi
Cell Death & Disease|August 21, 2023
Cancer stem cell immunoediting by IFNγClaudia Galassi, Lorenzo Galluzzi
Cell Death and Differentiation|March 29, 2022
BAX and BAK dynamics control mitochondrial DNA release during apoptosisTakahiro Yamazaki, Lorenzo Galluzzi
Methods in Enzymology|June 14, 2014
Preface: oncometabolism: a new field of research with profound therapeutic implicationsLorenzo Galluzzi, Guido Kroemer
Nature Immunology|August 24, 2022
Immuno-epigenetic escape of cancer stem cellsLorenzo Galluzzi, Guido Kroemer
Cells|June 2, 2021
Immunology of Cell Death in Cancer ImmunotherapyLorenzo Galluzzi, Abhishek D Garg
Oncoimmunology|November 18, 2017
CD103<sup>+</sup> cells at the forefront of anticancer immunityClaire Vanpouille-Box, Lorenzo Galluzzi
Pageof 60